Retraction: Samaha et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses 2021, 13, 989
- PMID: 34751680
- PMCID: PMC8577689
- DOI: 10.3390/v13112154
Retraction: Samaha et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses 2021, 13, 989
Abstract
The journal retracts the article, Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon [...].
Retraction of
-
Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.Viruses. 2021 May 26;13(6):989. doi: 10.3390/v13060989. Viruses. 2021. Retraction in: Viruses. 2021 Oct 26;13(11):2154. doi: 10.3390/v13112154 PMID: 34073401 Free PMC article. Retracted. Clinical Trial.
Similar articles
-
Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon.Viruses. 2021 May 26;13(6):989. doi: 10.3390/v13060989. Viruses. 2021. Retraction in: Viruses. 2021 Oct 26;13(11):2154. doi: 10.3390/v13112154 PMID: 34073401 Free PMC article. Retracted. Clinical Trial.
-
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z. Trials. 2020. PMID: 32513289 Free PMC article.
-
Ivermectin for preventing and treating COVID-19.Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3. Cochrane Database Syst Rev. 2022. PMID: 35726131 Free PMC article. Review.
-
Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment.Int J Environ Res Public Health. 2023 Jan 19;20(3):1835. doi: 10.3390/ijerph20031835. Int J Environ Res Public Health. 2023. PMID: 36767202 Free PMC article.
-
A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.Fundam Clin Pharmacol. 2021 Apr;35(2):260-276. doi: 10.1111/fcp.12644. Epub 2021 Jan 28. Fundam Clin Pharmacol. 2021. PMID: 33427370 Free PMC article. Review.
Cited by
-
Is Ivermectin Effective in Treating COVID-19?Front Pharmacol. 2022 Jun 21;13:858693. doi: 10.3389/fphar.2022.858693. eCollection 2022. Front Pharmacol. 2022. PMID: 35800451 Free PMC article.
-
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19.Pharmaceuticals (Basel). 2022 Aug 27;15(9):1068. doi: 10.3390/ph15091068. Pharmaceuticals (Basel). 2022. PMID: 36145289 Free PMC article. Review.
-
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors.Curr Issues Mol Biol. 2023 Jan 4;45(1):400-433. doi: 10.3390/cimb45010028. Curr Issues Mol Biol. 2023. PMID: 36661514 Free PMC article. Review.
-
A Randomized Controlled Trial of Combined Ivermectin and Zinc Sulfate versus Combined Hydroxychloroquine, Darunavir/Ritonavir, and Zinc Sulfate among Adult Patients with Asymptomatic or Mild Coronavirus-19 Infection.J Glob Infect Dis. 2022 Jun 29;14(2):69-74. doi: 10.4103/jgid.jgid_281_21. eCollection 2022 Apr-Jun. J Glob Infect Dis. 2022. PMID: 35910820 Free PMC article.
-
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021.J Antimicrob Chemother. 2022 Dec 23;78(1):242-251. doi: 10.1093/jac/dkac382. J Antimicrob Chemother. 2022. PMID: 36374569 Free PMC article.
References
-
- Samaha A.A., Mouawia H., Fawaz M., Hassan H., Salami A., Bazzal A.A., Saab H.B., Al-Wakeel M., Alsaabi A., Chouman M., et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses. 2021;13:989. doi: 10.3390/v13060989. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous